Deals
CASI Pharmaceuticals Raises $25M at 2% Premium via Accel Partners
|
CASI Pharmaceuticals (NASDAQ CM:CASI) announced that it has raised $25,099,997 in a Common Stock transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/128/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
CASI Pharmaceuticals (NASDAQ CM:CASI) announced that it has raised $25,099,997 in a Common Stock transaction.
Can-Fite BioPharma Limited (AMEX:CANF) announced that it has raised $9,000,002 in a Registered Direct transaction.
Graphite Corporation (OTC:GRPH) announced that it has secured up to $2,000,000 in a Structured Equity Line transaction.
Apollo Commercial Real Estate Finance (NYSE:ARI) announced that it has raised $197,680,000 in a Non-Convertible Preferred Stock transaction.